Biomarin Pharmaceutical Inc (BMRN)
83.72
-0.99
(-1.17%)
USD |
NASDAQ |
Jun 21, 16:00
83.75
+0.03
(+0.04%)
After-Hours: 20:00
Biomarin Pharmaceutical Shares Outstanding: 189.88M for April 22, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
| Date | Value |
|---|---|
| April 22, 2024 | 189.88M |
| March 31, 2024 | 189.78M |
| March 25, 2024 | 189.78M |
| March 15, 2024 | 188.73M |
| February 16, 2024 | 188.68M |
| December 31, 2023 | 188.60M |
| October 30, 2023 | 188.37M |
| September 30, 2023 | 188.34M |
| July 28, 2023 | 188.17M |
| June 30, 2023 | 188.15M |
| April 25, 2023 | 187.70M |
| March 31, 2023 | 187.60M |
| March 27, 2023 | 187.60M |
| March 15, 2023 | 186.59M |
| February 16, 2023 | 186.53M |
| December 31, 2022 | 186.25M |
| October 25, 2022 | 185.85M |
| September 30, 2022 | 185.82M |
| July 28, 2022 | 185.47M |
| June 30, 2022 | 185.45M |
| April 25, 2022 | 185.00M |
| March 31, 2022 | 184.90M |
| March 28, 2022 | 184.90M |
| March 04, 2022 | 184.05M |
| February 22, 2022 | 184.03M |
| Date | Value |
|---|---|
| December 31, 2021 | 183.91M |
| October 26, 2021 | 183.59M |
| September 30, 2021 | 183.57M |
| July 27, 2021 | 183.35M |
| June 30, 2021 | 183.32M |
| April 21, 2021 | 182.74M |
| March 31, 2021 | 182.67M |
| March 29, 2021 | 182.66M |
| March 05, 2021 | 181.87M |
| February 12, 2021 | 181.83M |
| December 31, 2020 | 181.74M |
| October 23, 2020 | 181.53M |
| September 30, 2020 | 181.49M |
| July 30, 2020 | 181.35M |
| June 30, 2020 | 181.15M |
| April 20, 2020 | 180.84M |
| March 31, 2020 | 180.76M |
| March 30, 2020 | 180.76M |
| March 06, 2020 | 180.07M |
| February 12, 2020 | 179.93M |
| December 31, 2019 | 179.84M |
| October 18, 2019 | 179.63M |
| September 30, 2019 | 179.60M |
| July 22, 2019 | 179.46M |
| June 30, 2019 | 179.43M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
179.43M
Minimum
Jun 30 2019
189.88M
Maximum
Apr 22 2024
184.27M
Average
183.97M
Median
Shares Outstanding Benchmarks
| Krystal Biotech Inc | 28.56M |
| Alnylam Pharmaceuticals Inc | 126.49M |
| Ligand Pharmaceuticals Inc | 17.96M |
| Blueprint Medicines Corp | 62.62M |
| BridgeBio Pharma Inc | 187.13M |